A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder

BACKGROUND: Long-term treatment is recommended in major depressive disorder (MDD) to prevent relapse and to restore functioning. The aim of this study (Orion; NCT01360866) was to assess the long-term safety, tolerability, and efficacy of open-label treatment with adjunctive brexpiprazole in adult pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hobart, Mary, Zhang, Peter, Skuban, Aleksandar, Brewer, Claudette, Hefting, Nanco, Sanchez, Raymond, McQuade, Robert D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494030/
https://www.ncbi.nlm.nih.gov/pubmed/30946704
http://dx.doi.org/10.1097/JCP.0000000000001034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494030/
https://www.ncbi.nlm.nih.gov/pubmed/30946704
http://dx.doi.org/10.1097/JCP.0000000000001034

Ejemplares similares